Gentile Susan
Known title: DirectorCIK: 0001508493
Associated companies
Transaction History
| HNST | ▲ Buy | Grant | 41,970 | $0 | 5/21/2026 | View on chart |
| HNST | ▲ Buy | Grant | 28,499 | $78K | 1/1/2026 | View on chart |
| HNST | ▲ Buy | Grant | 38,252 | $0 | 5/28/2025 | View on chart |
| HNST | ▲ Buy | Grant | 60,569 | $0 | 5/22/2024 | View on chart |
| HNST | ▲ Buy | Grant | 105,845 | $0 | 5/24/2023 | View on chart |
| HNST | ▲ Buy | Grant | 48,615 | $0 | 5/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
HNST: Earnings improve but business outlook remains uncertain
A recent Seeking Alpha article notes that The Honest Company posted better-than-expected earnings, showing improvement in revenue and margins. However, the piece also points to ongoing questions about the durability of its business model and growth prospects. The commentary comes as the stock trades near its long‑standing support level of $2.70.
HNST: Earnings improve but business outlook remains uncertain. A recent Seeking Alpha article notes that The Honest Company posted better-than-expected earnings, showing improvement in revenue and margins. However, the piece also points to ongoing questions about the durability of its business model and growth prospects. The commentary comes as the stock trades near its long‑standing support level of $2.70.